Can alprostadil improve liver failure in HIV-infected patients with severe acute viral hepatitis?

Journal of Infection

Volumn 37, Issue 1, 1998, Pages 84-86

  Reus, S ^a   Priego, M ^a   Boix, V ^a   Torrus D ^a   Portilla, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ACUTE HEPATITIS; ADULT; ARTICLE; CASE REPORT; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; MALE;

EID: 0031667521     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)91163-X     Document Type: Article

References (8)

1. Harrison PM, Hughes RD, Forbes A, Portmann B, Alexander GJM, Williams R. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. J Hepatol 1990; 10: 332-336.
2. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-1857.
3. Sinclair SB, Greig PD, Blendis LM et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J Clin Invest 1989; 84: 1063-1069.
4. Fiugerote RJ, Bain VG. Fulminant hepatic failure. Am J Gastroenterol 1993; 88: 1000-1010.
5. 1 prevents the development of multiple-organ failure. J Hepatol 1994; 20: 478-482.
6. 1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology 1996; 111: 710-715.
7. 1) has no beneficial effect in patients with either severe or fulminant hepatitis B [Abstract]. Hepatology 1990; 12: 875.
8. 2) in the treatment of fulminant hepatic failure (FHF) [Abstract]. Hepatology 1992; 16: 88A.